We have recently reported that a short course of morphine, starting 10 days after sciatic chronic constriction injury (CCI), prolonged the duration of mechanical allodynia for months after morphine ceased. Maintenance of this morphine-induced persistent sensitization was dependent on spinal NOD-like receptor protein 3 (NLRP3) inflammasomes-protein complexes that proteolytically activate interleukin-1b (IL-1b) via caspase-1. However, it is still unclear how NLRP3 inflammasome signaling is maintained long after morphine is cleared. Here, we demonstrate that spinal levels of the damage associated molecular patterns (DAMPs) high mobility group box 1 (HMGB1) and biglycan are elevated during morphine-induced persistent sensitization in male rats; that is, 5 weeks after cessation of morphine dosing. We also show that HMGB1 and biglycan levels are at least partly dependent on the initial activation of caspase-1, as well as Toll like receptor 4 (TLR4) and the purinergic receptor P2X7R-receptors responsible for priming and activation of NLRP3 inflammasomes. Finally, pharmacological attenuation of the DAMPs HMGB1, biglycan, heat shock protein 90 and fibronectin persistently reversed morphineprolonged allodynia. We conclude that after peripheral nerve injury, morphine treatment results in persistent DAMP release via TLR4, P2X7R and caspase-1, which are involved in formation/activation of NLRP3 inflammasomes. These DAMPs are responsible for maintaining persistent allodynia, which may be due to engagement of a positive feedback loop, in which NLRP3 inflammasomes are persistently activated by DAMPs signaling at TLR4 and P2X7R.
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Introduction
Opioids remain a gold-standard analgesic for moderateto-severe chronic pain. Despite the recent escalation in opioid prescriptions for chronic pain, there are no clinical studies that have rigorously evaluated the long-term consequences of opioid use (Chou et al., 2015) . Beyond simply an absence of benefit, there is growing evidence of harm among adults prescribed long-term opioid therapy (Chou et al., 2015; Frank et al., 2017; Hoffman et al., 2017; Sommer, 2017) . We have discovered an additional negative consequence for pain in rats: a 5-day course of a moderate morphine dose, starting 10 days after sciatic chronic constriction injury (CCI), prolonged the duration of CCI-allodynia for months after morphine ceased (Grace et al., 2016) . Maintenance of this morphineinduced persistent sensitization was dependent on spinal NOD-like receptor protein 3 (NLRP3) inflammasomes-protein complexes that proteolytically activate interleukin-1b (IL-1b) via caspase-1 (Grace et al., 2016). However, an unresolved question from our study is how NLRP3 inflammasome signaling is maintained long after morphine is cleared (Grace et al., 2016) .
NLRP3 inflammasomes can be primed and activated by signaling through Toll like receptor 4 (TLR4) and the purinergic receptor P2X7, and both receptors are essential for morphine-induced persistent sensitization (Grace et al., 2016) . TLR4 and P2X7R are activated after peripheral nerve injury by endogenous damage associated molecular patterns (DAMPs) that are released by stressed cells in the spinal cord (Grace et al., 2014) . As a consequence of inflammasome activation, IL-1b may exacerbate cellular DAMP release (e.g. by disrupting glutamate homeostasis). As morphine-induced persistent sensitization was associated with persistent downregulation of the spinal astrocyte glutamate transporter GLT-1 (Grace et al., 2016) , exacerbated DAMP release could be a consequence that leads to continued activation of NLRP3 inflammasomes in a positive feedback loop.
The first of three goals of this study was to determine whether the spinal DAMPs high mobility group box 1 (HMGB1) and
